Taiwan FDA registration 36cc58982c6a35e5491e43fa93885161
Quickeli Yazi N-terminal brain natriuretic peptide precursor test reagent
TW: 快得利揣耶濟N端腦鈉肽前體檢驗試劑
Taiwan·Risk Class 2·Quidel Cardiovascular Inc.·Registered Jul 23, 2015 – Jul 23, 2025ExpiredRegistration details
- Analysis ID
- 36cc58982c6a35e5491e43fa93885161
- Customs Code
- DHA05602752701
Company information
- Manufacturer
- Quidel Cardiovascular Inc.
- Manufacturer Country
- United States
- Authorized Representative
- BIO-CHECK LABORATORIES LTD.
Product details
- Intended Use
- N-terminal brain natriuretic peptide precursor (NT-proBNP) in EDTA anticoagulated whole blood and plasma samples was quantitatively determined by immunofluorescence analysis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1117 Type B diuretic 鈉肽試驗系統;; A.1660 Quality Material (Analysis Only)
- Import Information
- import
Dates and status
- Registration Date
- Jul 23, 2015
- Expiry Date
- Jul 23, 2025
About this record
Access comprehensive regulatory information for Quickeli Yazi N-terminal brain natriuretic peptide precursor test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 36cc58982c6a35e5491e43fa93885161 and manufactured by Quidel Cardiovascular Inc.. The authorized representative in Taiwan is BIO-CHECK LABORATORIES LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices